| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |